{"filing":{"accession_number":"0001213900-26-058997","cik":"0001782107","ticker":null,"company_name":"Onconetix, Inc.","form":"8-K","filing_date":"2026-05-19","report_date":null,"primary_document":"ea0291543-8k_onconetix.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390026058997/ea0291543-8k_onconetix.htm"},"classifications":[{"id":233,"accession_number":"0001213900-26-058997","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"This disclosure reports implementation of a 1-for-10 reverse stock split approved by stockholders, effective May 21, 2026, primarily to achieve Nasdaq minimum bid price compliance. While Item 5.03 covers amendments to articles and bylaws, the reverse stock split is a material capital structure event affecting all shareholders' share counts and potential delisting risk mitigation, but does not fit neatly into the more specific event categories (it is neither a routine bylaw amendment nor a delisting notice itself). The materiality stems from the significant reduction in outstanding shares and the company's apparent compliance pressure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:23:23.923437+00:00","company_name":"Onconetix, Inc.","ticker":null,"filing_date":"2026-05-19"},{"id":234,"accession_number":"0001213900-26-058997","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a reverse stock split announced on May 19, 2026. While reverse stock splits are material corporate actions that affect share structure and are typically disclosed under Item 8.01 (Other Events), this event does not fit neatly into the more specific taxonomy categories. A reverse stock split can signal financial distress or be a technical measure to maintain listing compliance, making it material to investors' assessment of the registrant's financial condition and stock structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-20T02:23:23.923437+00:00","company_name":"Onconetix, Inc.","ticker":null,"filing_date":"2026-05-19"}]}